GlassScriptPhysician profile
James Kotick
NPI 1336438704
$11,002.65
in general payments reported to CMS, 2019-2025
26 companies · $2,318 in 2025
The $2,318 reported for 2025 was more than what 85% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $196 · 2021: $688 · 2022: $404 · 2023: $3,542 · 2024: $2,878 · 2025: $2,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,243 · Honoraria: $2,750 · Food and Beverage: $1,575 · Travel and Lodging: $130 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,243.41 |
| Honoraria | $2,750.00 |
| Food and Beverage | $1,575.01 |
| Travel and Lodging | $130.00 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $4,540.39 | 2019-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Davol INC. | $2,906.02 | 2022-2023 | |
| Allergan, INC. | $1,152.43 | 2019-2022 | |
| Abbvie INC. | $828.26 | 2023-2025 | |
| Stryker Corporation | $416.62 | 2019-2025 | Spy-Phi System |
| Smith+Nephew, INC. | $167.40 | 2021-2023 | Pico |
| Mentor Worldwide LLC | $147.80 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $125.02 | 2024 | |
| Vioptix INC | $95.92 | 2024-2025 | T. Ox Tissue Oximeter |
| Checkpoint Surgical, INC | $84.05 | 2019-2024 | Checkpoint Stimulators |
| Medtronic, INC. | $78.17 | 2021-2023 | Surgipro Ll |
| Baxter Healthcare | $67.19 | 2023 | Artiss, Perclot |
| Mimedx Group, INC. | $59.09 | 2024-2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $42.10 | 2025 | |
| Tela Bio, INC. | $41.67 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $35.66 | 2025 | |
| Surgenex LLC | $32.27 | 2025 | Renograft, Surgraft, Pellograft |
| Bioventus LLC | $27.46 | 2022 | |
| Solventum Corporation | $24.60 | 2024 | Prevena |
| Axogen | $24.40 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.67 | 2025 | Exparel |
| Endo Pharmaceuticals INC. | $19.96 | 2024 | Xiaflex |
| Sientra, INC. | $17.84 | 2021 | |
| Bard Peripheral Vascular, INC. | $17.75 | 2021 | |
| Omeza LLC | $14.71 | 2024 | |
| Galderma Laboratories, L.P. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kotick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.